PERKINELMER, INC.

(PKI)
  Rapport
Geschatte realtime Cboe BZX  -  20/05 18:57:47 CEST
143.21 USD   -0.24%
18/05PERKINELMER, INC. : Barclays verlaagt advies van Neutraal naar Verkopen
MM
03/05Aangepaste winst en inkomsten van PerkinElmer over het eerste kwartaal dalen t.o.v. vorig jaar; verhoogt prognose voor het hele jaar 2022
MT
03/05Winstflits (PKI) PERKINELMER boekt inkomsten over het eerste kwartaal $1,26B
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť PERKINELMER, INC.
10/05PERKINELMER INC Management's Discussion and Analysis of Financial Condition and Result..
AQ
03/05PERKINELMER : Q1 Earnings Snapshot
AQ
03/05PERKINELMER INC : Results of Operations and Financial Condition (form 8-K)
AQ
03/05PerkinElmer Announces Financial Results for the First Quarter of 2022
BU
29/04PERKINELMER INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
28/04PERKINELMER : Showcases Leading Informatics Solutions and Strategic Services at Bio-IT Wor..
PU
28/04PerkinElmer Board Declares Quarterly Dividend
BU
18/04PERKINELMER : Oxford Immunotec Debuts Global Immunology Services Offering at World Vaccine..
PU
14/04PERKINELMER : Scitara announces collaboration with PerkinElmer Informatics to create new m..
PU
12/04PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022
BU
08/04PERKINELMER : Showcases Expanded Technology and Solutions Portfolio to Accelerate Cancer R..
PU
07/04PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega..
BU
04/04PerkinElmer Introduces First Ready-to-use HTRFģ and AlphaLISAģ Assay Kits for CHO HCP I..
BU
01/04PERKINELMER INC : Regulation FD Disclosure (form 8-K)
AQ
15/03PERKINELMER : Expands Salmonella Testing Portfolio with Solus One™ Detection Kit for..
PU
09/03PERKINELMER : Launches Innovative FT-IR Platform for Quality and Safety Testing of Wine, D..
PU
03/03PERKINELMER INC Management's Discussion and Analysis of Financial Condition and Result..
AQ
02/03PERKINELMER : and P1 Fuels team up to boost sustainable mobility through fossil-free fuels
PU
02/03PERKINELMER : Launches ChemDrawģ V21 Software, Empowering Researchers to Rapidly Create Ch..
PU
01/03PerkinElmer to Present at Upcoming Investor Conferences
BU
10/02PerkinElmer to Present at Citi's 2022 Virtual Healthcare Conference
BU
03/02PERKINELMER : to Showcase Expanded Life Science / Cell & Gene Therapy Portfolios and Autom..
PU
03/02U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Test..
BU
02/02PERKINELMER : and P1 Fuels team up to boost sustainable mobility through fossil-free fuels
PU
01/02PERKINELMER : Q4 Earnings Snapshot
AQ
01/02PERKINELMER : Q4 2021 Non-GAAP Reconciliations
PU
01/02PERKINELMER : Announces Financial Results for the Fourth Quarter and Full Year of 2021 - F..
PU
01/02PERKINELMER INC : Results of Operations and Financial Condition (form 8-K)
AQ
01/02PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
BU
27/01PerkinElmer Board Declares Quarterly Dividend
BU
11/01PERKINELMER : 2022 JPM Healthcare Conference Presentation
PU
11/01PERKINELMER : Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1..
PU
11/01PERKINELMER INC : Results of Operations and Financial Condition (form 8-K)
AQ
11/01PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February ..
BU
2021PerkinElmer to Present Virtually at J.P. Morgan Healthcare Conference
BU
2021PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Su..
BU
2021PerkinElmer Confirms That Omicron Variant Does Not Impact SARS-CoV-2 Detection Capabili..
BU
2021PerkinElmer to Present at Evercore ISI HealthCONx Conference 2021
BU
2021PERKINELMER INC Management's Discussion and Analysis of Financial Condition and Result..
AQ
2021PerkinElmer to Present at 2021 Stifel Healthcare Conference
BU
2021BioLegend, Inc. and subsidiaries Index to financial statements - Form 8-K/A
PU
2021PERKINELMER INC Completion of Acquisition or Disposition of Assets, Financial Statemen..
AQ
2021PERKINELMER : Q3 Earnings Snapshot
AQ
2021PerkinElmer Announces Financial Results for the Third Quarter of 2021 - Form 8-K
PU
2021PERKINELMER INC : Results of Operations and Financial Condition (form 8-K)
AQ
2021PerkinElmer Announces Financial Results for the Third Quarter of 2021
BU
2021PerkinElmer Releases 2021 Corporate Social Responsibility Report
BU
2021PerkinElmer Board Declares Quarterly Dividend
BU
2021PERKINELMER : Signals Research™ Suite Platform Integrates Scientific Data Silos and ..
PU
2021PERKINELMER : Participates in NIST Program to Advance Cannabis and Hemp Testing Standardiz..
PU
2021PERKINELMER : and Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-C..
BU
2021PERKINELMER : Collaborates With Leading Life Science Incubators LabCentral and MBC BioLabs..
PU
2021PERKINELMER : Schedules Earnings Call for Tuesday, November 2, 2021
BU
2021PERKINELMER : Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel
BU
2021PERKINELMER : EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authoriz..
BU
2021PERKINELMER : Introduces Next Generation Cell Image Analysis and Management Software Platf..
PU
2021PERKINELMER : Registration Statement on Form S-3 (Form 8-K)
PU
2021PERKINELMER INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021PERKINELMER : Mount Sinai Health System and PerkinElmer Collaborate to Accelerate COVID-19..
PU
2021PERKINELMER : Completion of Acquisition or Disposition of Assets (Form 8-K)
PU
2021PERKINELMER INC : Completion of Acquisition or Disposition of Assets, Creation of a Direct..
AQ
2021PERKINELMER : Completes Acquisition of Antibody and Reagent Leader BioLegend
BU
2021PERKINELMER INC : Entry into a Material Definitive Agreement, Other Events (form 8-K)
AQ
2021PERKINELMER : Prices Offering of Senior Notes
BU
2021PERKINELMER : Introduces IndiScope™ Solution to Help Dairy Collection Points Test Mi..
PU
2021PERKINELMER INC : Entry into a Material Definitive Agreement, Termination of a Material De..
AQ
2021PERKINELMER : to Present at 2021 Baird Global Healthcare Conference
BU
2021PERKINELMER INC : Entry into a Material Definitive Agreement, Creation of a Direct Financi..
AQ
2021PERKINELMER : Management's Discussion and Analysis of Financial Condition and Results of O..
AQ
2021PERKINELMER : to Acquire Antibody and Reagent Leader BioLegend Transformative deal signifi..
PU
2021PERKINELMER INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity ..
AQ
2021PERKINELMER : to pay $5.25B for antibody maker BioLegend
AQ
2021PERKINELMER : Q2 2021 Earnings Presentation
PU
2021PERKINELMER : to Acquire BioLegend
PU
2021PERKINELMER : BioLegend Acquisition Infographic
PU
1  2  3  4  5  6  7  8  9Volgende
OfficiŽle publicaties
Volgende evenement op PERKINELMER, INC.